{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:03:46Z","timestamp":1772085826172,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Procalcitonin (PCT) is a biomarker for bacterial infections, with controversial utility in diagnosing hospital-acquired pneumonia (HAP) in neurosurgical intensive care unit (NICU) patients. Establishing an optimal PCT cutoff value could enhance diagnostic accuracy. This retrospective single-center study included NICU patients hospitalized between January 1, 2021, and December 31, 2022, who underwent routine serum PCT measurement. HAP was diagnosed based on clinical, biochemical, microbiological, and radiological data. The optimal PCT cutoff value was identified using the Youden Index. Associations between PCT levels, radiological findings, sputum cultures, and confirmed HAP were analyzed using chi-square tests. A multivariate logistic regression was performed to identify independent predictors of elevated PCT. Among 2363 patients, 193 met inclusion criteria, and 148 were diagnosed with HAP. The optimal PCT cutoff value was 0.095 ng\/mL, yielding a sensitivity of 89.2% and specificity of 93.3% (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). This cutoff resulted in a positive likelihood ratio of 13.3 and a negative likelihood ratio of 0.116. Radiological signs of pneumonia and positive sputum cultures were observed in 48.4% and 78.4% of HAP cases, respectively, but neither showed a significant association with HAP (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.135 and\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.056). Leukocytosis was significantly associated with HAP but had low specificity, while CRP showed a non-significant trend. In multivariate analysis, only confirmed HAP independently predicted PCT elevation. PCT, with a cutoff value of 0.095 ng\/mL, shows high diagnostic accuracy for HAP in NICU patients and could enhance early identification and treatment. Our findings suggest that elevated PCT is primarily driven by HAP rather than non-infectious inflammatory triggers such as trauma or recent surgery. Further prospective studies are warranted to validate these findings.\n                  <\/jats:p>","DOI":"10.1007\/s10143-025-03529-7","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T02:59:33Z","timestamp":1745204373000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum procalcitonin in the diagnosis of pneumonia in the neurosurgical intensive care unit"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0076-3170","authenticated-orcid":false,"given":"Manou","family":"Overstijns","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Scheffler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Buttler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"El Rahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"issue":"5","key":"3529_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/phar.2112","volume":"38","author":"EW Covington","year":"2018","unstructured":"Covington EW, Roberts MZ, Dong J (2018) Procalcitonin monitoring as a guide for antimicrobial therapy: A review of current literature. Pharmacotherapy May 38(5):569\u2013581. https:\/\/doi.org\/10.1002\/phar.2112","journal-title":"Pharmacotherapy May"},{"issue":"2","key":"3529_CR2","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00003246-200002000-00028","volume":"28","author":"MW Nijsten","year":"2000","unstructured":"Nijsten MW, Olinga P, The TH et al (2000) Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med Feb 28(2):458\u2013461. https:\/\/doi.org\/10.1097\/00003246-200002000-00028","journal-title":"Crit Care Med Feb"},{"issue":"5","key":"3529_CR3","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1055\/s-2003-41304","volume":"35","author":"NG Morgenthaler","year":"2003","unstructured":"Morgenthaler NG, Struck J, Chancerelle Y et al (2003) Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Horm Metab Res May 35(5):290\u2013295. https:\/\/doi.org\/10.1055\/s-2003-41304","journal-title":"Horm Metab Res May"},{"issue":"2","key":"3529_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.nec.2017.11.008","volume":"29","author":"KM Busl","year":"2018","unstructured":"Busl KM (2018) Nosocomial infections in the neurointensive care unit. Neurosurg Clin N Am Apr 29(2):299\u2013314. https:\/\/doi.org\/10.1016\/j.nec.2017.11.008","journal-title":"Neurosurg Clin N Am Apr"},{"issue":"21","key":"3529_CR5","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1001\/jama.2009.1754","volume":"02","author":"JL Vincent","year":"2009","unstructured":"Vincent JL, Rello J, Marshall J et al (2009) International study of the prevalence and outcomes of infection in intensive care units. JAMA Dec 02(21):2323\u20132329. https:\/\/doi.org\/10.1001\/jama.2009.1754","journal-title":"JAMA Dec"},{"issue":"8","key":"3529_CR6","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/j.1469-0691.2005.01205.x","volume":"11","author":"G Laifer","year":"2005","unstructured":"Laifer G, Wasner M, Sendi P et al (2005) Dynamics of serum procalcitonin in patients after major neurosurgery. Clin Microbiol Infect Aug 11(8):679\u2013681. https:\/\/doi.org\/10.1111\/j.1469-0691.2005.01205.x","journal-title":"Clin Microbiol Infect Aug"},{"key":"3529_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2334-13-158","volume":"01","author":"A Hohn","year":"2013","unstructured":"Hohn A, Schroeder S, Gehrt A et al (2013) Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. BMC Infect Dis Apr 01:13:158. https:\/\/doi.org\/10.1186\/1471-2334-13-158","journal-title":"BMC Infect Dis Apr"},{"issue":"10","key":"3529_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.JAA.0000580528.33851.0c","volume":"32","author":"R Hunton","year":"2019","unstructured":"Hunton R (2019) Updated concepts in the diagnosis and management of community-acquired pneumonia. JAAPA Oct 32(10):18\u201323. https:\/\/doi.org\/10.1097\/01.JAA.0000580528.33851.0c","journal-title":"JAAPA Oct"},{"key":"3529_CR9","doi-asserted-by":"publisher","unstructured":"Rotman LE, Agee BS, Chagoya G, Davis MC, Markert JM (2018) Clinical Utility of Serum Procalcitonin Level and Infection in the Neurosurgical Intensive Care Unit. World Neurosurg. Apr;112:e368-e374. https:\/\/doi.org\/10.1016\/j.wneu.2018.01.050","DOI":"10.1016\/j.wneu.2018.01.050"},{"issue":"5","key":"3529_CR10","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"01","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M et al (2016) Management of adults with Hospital-acquired and Ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis Sep 01(5):e61\u2013e111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis Sep"},{"issue":"5","key":"3529_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","volume":"36","author":"TC Horan","year":"2008","unstructured":"Horan TC, Andrus M, Dudeck MA (2008) CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control Jun 36(5):309\u2013332. https:\/\/doi.org\/10.1016\/j.ajic.2008.03.002","journal-title":"Am J Infect Control Jun"},{"issue":"8","key":"3529_CR12","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/aas.12749","volume":"60","author":"JM Karhu","year":"2016","unstructured":"Karhu JM, Ala-Kokko TI, Ahvenj\u00e4rvi LK, Rauvala E, Ohtonen P, Syrj\u00e4l\u00e4 HP (2016) Early chest computed tomography in adult acute severe community-acquired pneumonia patients treated in the intensive care unit. Acta Anaesthesiol Scand Sep 60(8):1102\u20131110. https:\/\/doi.org\/10.1111\/aas.12749","journal-title":"Acta Anaesthesiol Scand Sep"},{"issue":"1","key":"3529_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S1473-3099(17)30592-3","volume":"18","author":"P Schuetz","year":"2018","unstructured":"Schuetz P, Wirz Y, Sager R et al (2018) Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis Jan 18(1):95\u2013107. https:\/\/doi.org\/10.1016\/S1473-3099(17)30592-3","journal-title":"Lancet Infect Dis Jan"},{"issue":"1","key":"3529_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1186\/s12877-022-03658-4","volume":"14","author":"G Gavazzi","year":"2022","unstructured":"Gavazzi G, Drevet S, Debray M et al (2022) Procalcitonin to reduce exposure to antibiotics and individualise treatment in hospitalised old patients with pneumonia: a randomised study. BMC Geriatr Dec 14(1):965. https:\/\/doi.org\/10.1186\/s12877-022-03658-4","journal-title":"BMC Geriatr Dec"},{"issue":"1","key":"3529_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13054-018-2125-7","volume":"15","author":"Y Wirz","year":"2018","unstructured":"Wirz Y, Meier MA, Bouadma L et al (2018) Effect of procalcitonin-guided antibiotic treatment on clinical outcomes in intensive care unit patients with infection and sepsis patients: a patient-level meta-analysis of randomized trials. Crit Care Aug 15(1):191. https:\/\/doi.org\/10.1186\/s13054-018-2125-7","journal-title":"Crit Care Aug"},{"issue":"4","key":"3529_CR16","doi-asserted-by":"publisher","first-page":"412","DOI":"10.4187\/respcare.00979","volume":"56","author":"J Dallas","year":"2011","unstructured":"Dallas J, Brown SM, Hock K et al (2011) Diagnostic utility of plasma procalcitonin for nosocomial pneumonia in the intensive care unit setting. Respir Care Apr 56(4):412\u2013419. https:\/\/doi.org\/10.4187\/respcare.00979","journal-title":"Respir Care Apr"},{"issue":"12","key":"3529_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1373\/clinchem.2019.306787","volume":"65","author":"D Wussler","year":"2019","unstructured":"Wussler D, Kozhuharov N, Tavares Oliveira M et al (2019) Clinical utility of procalcitonin in the diagnosis of pneumonia. Clin Chem Dec 65(12):1532\u20131542. https:\/\/doi.org\/10.1373\/clinchem.2019.306787","journal-title":"Clin Chem Dec"},{"issue":"1","key":"3529_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s12028-013-9844-z","volume":"21","author":"C Muroi","year":"2014","unstructured":"Muroi C, Lemb JB, Hugelshofer M, Seule M, Bellut D, Keller E (2014) Early systemic procalcitonin levels in patients with aneurysmal subarachnoid hemorrhage. Neurocrit Care Aug 21(1):73\u201377. https:\/\/doi.org\/10.1007\/s12028-013-9844-z","journal-title":"Neurocrit Care Aug"},{"issue":"3","key":"3529_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jemermed.2007.11.042","volume":"36","author":"GE Hayden","year":"2009","unstructured":"Hayden GE, Wrenn KW (2009) Chest radiograph vs. computed tomography scan in the evaluation for pneumonia. J Emerg Med Apr 36(3):266\u2013270. https:\/\/doi.org\/10.1016\/j.jemermed.2007.11.042","journal-title":"J Emerg Med Apr"},{"issue":"4","key":"3529_CR20","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/MAJ.0b013e31818ad805","volume":"337","author":"JT Hagaman","year":"2009","unstructured":"Hagaman JT, Rouan GW, Shipley RT, Panos RJ (2009) Admission chest radiograph lacks sensitivity in the diagnosis of community-acquired pneumonia. Am J Med Sci Apr 337(4):236\u2013240. https:\/\/doi.org\/10.1097\/MAJ.0b013e31818ad805","journal-title":"Am J Med Sci Apr"},{"key":"3529_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1186\/1471-2334-14-452","volume":"22","author":"SK Yang","year":"2014","unstructured":"Yang SK, Xiao L, Zhang H et al (2014) Significance of serum procalcitonin as biomarker for detection of bacterial peritonitis: a systematic review and meta-analysis. BMC Infect Dis Aug 22:14:452. https:\/\/doi.org\/10.1186\/1471-2334-14-452","journal-title":"BMC Infect Dis Aug"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03529-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03529-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:15:20Z","timestamp":1772079320000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03529-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3529"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03529-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"16 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"EK-Freiburg 24-1164-S1-retro","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical (IRB) approval"}},{"value":"Not applicable in concordance with ethical committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"STARD","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Reporting checklist"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"373"}}